Knowledge
Sphere
The scientific process, made readable. We map every known benefit and risk of a drug or molecule — from gold-standard clinical trials to patient forums — into a single visual hierarchy of evidence.
Science is hard. Understanding it shouldn't be.
Every drug generates a spectrum of evidence — from indisputable clinical trial data to whispers on Reddit. The Knowledge Sphere maps this entire spectrum visually, so you can see at a glance what is proven, what is being studied, and what is purely anecdotal. No medical degree required.
How the Sphere Works
Four concentric layers represent the hierarchy of scientific evidence — from proven fact to frontier speculation.
Examples below are drawn from the GLP-1 sphere.
Indisputable facts backed by Phase III clinical trials and regulatory approval. These are the hard truths.
Passed major clinical trials, recently approved or in final regulatory stages. Highly reliable.
Evidence exists (Phase II trials or large observational studies) but not yet settled law in medicine.
Patient forums, case reports, or very early observations. The wild west of emerging data.
Available Spheres
GLP-1
Glucagon-Like Peptide-1 Receptor Agonists
GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) mimic a gut hormone that regulates blood sugar and appetite. Originally developed for type 2 diabetes, they have since demonstrated broad effects across cardiovascular, neurological, and metabolic systems.
The 60-year-old diabetes drug with surprising anti-aging and cancer-prevention signals.